Latest News about Stories That Matter
Recent news which mentions Stories That Matter
From Benzinga
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
November 01, 2024
Tickers
ARGX
From Benzinga
Apple Q4 Results 'Better-Than-Feared': Analysts Highlight iPhone 16 Demand, Apple Intelligence Opportunity After 'Rock Solid Quarter'
November 01, 2024
From Benzinga
Shock October Jobs Report Leaves Fed In 'Tight Spot': Experts Say Interest Rate Cuts Ahead
November 01, 2024
From Benzinga
What's Going On With Rivian Stock Today?
November 01, 2024
From Benzinga
Oil Prices Almost Recoup Week Losses As Iran Mulls Retaliatory Attack On Israel Prior To US Elections
November 01, 2024
From Benzinga
From Benzinga
US Manufacturing Shrinks For Seventh Straight Month, Contraction Accelerates In October
November 01, 2024
Tickers
NEWS
From Benzinga
What's Going On With Taiwan Semiconductor and ASML Stocks On Friday?
November 01, 2024
From Benzinga
Phoenix Motor Drops Despite Revenue Surge, New EV Contracts
November 01, 2024
From Benzinga
Nate Silver Says Kamala Harris 'May Need Backup Plans' If The 'Blue Wal' Is Split But Sees The Race As 'A Near Coin Flip'
November 01, 2024
Tickers
NEWS
From Benzinga
Why Is Infrastructure Construction Company MasTec Stock Surging Today?
November 01, 2024
From Benzinga
Stocks Rebound After Selloff As October Hiring Slump Fuels Interest Rate Cut Bets: 10 ETFs To Watch Friday
November 01, 2024
From Benzinga
Church & Dwight Surpasses Q3 Expectations: Strong Sales Growth And Brand Investments Fuel Gains
November 01, 2024
From Benzinga
Can Blockchain Transform Finance Or Will Banks Like Citi, JPMorgan Wield It For Efficiency?
November 01, 2024
From Benzinga
Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: 'AI Enthusiasm And Potential Is Not Enough"
November 01, 2024
From Benzinga
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
November 01, 2024
From Benzinga
LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4
November 01, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Nvidia's Run:ai Acquisition Draws European Regulatory Scrutiny On Competition Concerns
November 01, 2024
From Benzinga
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
From Benzinga
Analyst Throws Support Behind Intel CEO Gelsinger After Better-Than-Expected Q3 Results: 'If You're Questioning Pat As The Leader, Then Who Else?'
November 01, 2024
From Benzinga
Apple Shares Dip In Pre-Market Trading: What's Going On
November 01, 2024
From Benzinga
FuboTV Q3 Earnings: Subscribers Grow 9% To 1.61 Million, Narrows EPS Loss, Raises Annual Outlook
November 01, 2024
From Benzinga
Dominion Energy Q3 Results: Revenue Miss, Earnings Beat, And Updated FY24 Guidance
November 01, 2024
From Benzinga
ArcBest Shares Fall On Q3 Revenue Miss, Productivity Gains Can't Offset Shipment Decline
November 01, 2024
From Benzinga
US Economy Adds Only 12,000 Jobs In October, Sharply Misses Estimates As Hurricane, Strikes Pummel Hiring
November 01, 2024
Tickers
ECON
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.